These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15944807)

  • 21. Erythropoietin protects post-ischemic hearts by preventing extracellular matrix degradation: role of Jak2-ERK pathway.
    Chan CY; Chen YS; Lee HH; Huang HS; Lai YL; Chen CF; Ma MC
    Life Sci; 2007 Aug; 81(9):717-23. PubMed ID: 17707437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Failure of erythropoietin to render jeopardized ischemic myocardium amenable to incremental salvage by early reperfusion.
    French CJ; Zaman AK; Sobel BE
    Coron Artery Dis; 2009 Jun; 20(4):295-9. PubMed ID: 19440068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infarct size limitation by adrenomedullin: protein kinase A but not PI3-kinase is linked to mitochondrial KCa channels.
    Nishida H; Sato T; Miyazaki M; Nakaya H
    Cardiovasc Res; 2008 Jan; 77(2):398-405. PubMed ID: 17706952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythropoietin alleviates post-ischemic injury of rat hearts by attenuating nitrosative stress.
    Lu MJ; Chen YS; Huang HS; Ma MC
    Life Sci; 2012 May; 90(19-20):776-84. PubMed ID: 22521289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cardioprotective effects of sodium ferulate mediated by nitric oxide on ischemia-reperfusion injured myocardium: experiment with isolated rat hearts].
    Liu JC; Kang J; Shao LJ; He M
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):987-91. PubMed ID: 16759542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythropoietin protects the heart from ventricular arrhythmia during ischemia and reperfusion via neuronal nitric-oxide synthase.
    Burger DE; Xiang FL; Hammoud L; Jones DL; Feng Q
    J Pharmacol Exp Ther; 2009 Jun; 329(3):900-7. PubMed ID: 19307451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic erythropoietin treatment limits infarct-size in the myocardium in vitro.
    Bullard AJ; Yellon DM
    Cardiovasc Drugs Ther; 2005 Oct; 19(5):333-6. PubMed ID: 16382295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway.
    Zhu M; Feng J; Lucchinetti E; Fischer G; Xu L; Pedrazzini T; Schaub MC; Zaugg M
    Cardiovasc Res; 2006 Oct; 72(1):152-62. PubMed ID: 16901477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythropoietin protects myocardium against ischemia-reperfusion injury under moderate hyperglycemia.
    Jun JH; Jun NH; Shim JK; Shin EJ; Kwak YL
    Eur J Pharmacol; 2014 Dec; 745():1-9. PubMed ID: 25446919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection.
    Davidson SM; Hausenloy D; Duchen MR; Yellon DM
    Int J Biochem Cell Biol; 2006 Mar; 38(3):414-9. PubMed ID: 16280253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erythropoietin protects from reperfusion-induced myocardial injury by enhancing coronary endothelial nitric oxide production.
    Mihov D; Bogdanov N; Grenacher B; Gassmann M; Zünd G; Bogdanova A; Tavakoli R
    Eur J Cardiothorac Surg; 2009 May; 35(5):839-46; discussion 846. PubMed ID: 19237290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ischaemic postconditioning protects isolated mouse hearts against ischaemia/reperfusion injury via sphingosine kinase isoform-1 activation.
    Jin ZQ; Karliner JS; Vessey DA
    Cardiovasc Res; 2008 Jul; 79(1):134-40. PubMed ID: 18334546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effect of erythropoietin on renal ischemia and reperfusion injury.
    Ates E; Yalcin AU; Yilmaz S; Koken T; Tokyol C
    ANZ J Surg; 2005 Dec; 75(12):1100-5. PubMed ID: 16398819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (S)-1-(alpha-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (CKD712) reduces rat myocardial apoptosis against ischemia and reperfusion injury by activation of phosphatidylinositol 3-kinase/Akt signaling and anti-inflammatory action in vivo.
    Jin YC; Lee YS; Kim YM; Seo HG; Lee JH; Kim HJ; Yun-Choi HS; Chang KC
    J Pharmacol Exp Ther; 2009 Aug; 330(2):440-8. PubMed ID: 19458286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
    Liu YN; Zhou ZM; Chen P
    Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardioprotection of sevoflurane postconditioning by activating extracellular signal-regulated kinase 1/2 in isolated rat hearts.
    Chen HT; Yang CX; Li H; Zhang CJ; Wen XJ; Zhou J; Fan YL; Huang T; Zeng YM
    Acta Pharmacol Sin; 2008 Aug; 29(8):931-41. PubMed ID: 18664326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia/reperfusion injury.
    Cai Z; Semenza GL
    Circulation; 2004 May; 109(17):2050-3. PubMed ID: 15117842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct cardiac actions of erythropoietin (EPO): effects on cardiac contractility, BNP secretion and ischaemia/reperfusion injury.
    Piuhola J; Kerkelä R; Keenan JI; Hampton MB; Richards AM; Pemberton CJ
    Clin Sci (Lond); 2008 Feb; 114(4):293-304. PubMed ID: 17919123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythropoietin attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain.
    Kumral A; Baskin H; Yesilirmak DC; Ergur BU; Aykan S; Genc S; Genc K; Yilmaz O; Tugyan K; Giray O; Duman N; Ozkan H
    Neonatology; 2007; 92(4):269-78. PubMed ID: 17627093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The myocardial infarct size-limiting and antiarrhythmic effects of acyl-CoA:cholesterol acyltransferase inhibitor VULM 1457 protect the hearts of diabetic-hypercholesterolaemic rats against ischaemia/reperfusion injury both in vitro and in vivo.
    Adameová A; Ravingerová T; Svec P; Faberová V; Kuzelová M
    Eur J Pharmacol; 2007 Dec; 576(1-3):114-21. PubMed ID: 17764671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.